Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination.

Clicks: 308
ID: 19987
2019
Although the medicinal properties of species have been known for centuries, the interest on its main active secondary metabolites as therapeutic alternatives for several pathologies has grown in recent years. This potential use has been a revolution worldwide concerning public health, production, use and sale of cannabis, and has led inclusively to legislation changes in some countries. The scientific advances and concerns of the scientific community have allowed a better understanding of cannabis derivatives as pharmacological options in several conditions, such as appetite stimulation, pain treatment, skin pathologies, anticonvulsant therapy, neurodegenerative diseases, and infectious diseases. However, there is some controversy regarding the legal and ethical implications of their use and routes of administration, also concerning the adverse health consequences and deaths attributed to marijuana consumption, and these represent some of the complexities associated with the use of these compounds as therapeutic drugs. This review comprehends the main secondary metabolites of , approaching their therapeutic potential and applications, as well as their potential risks, in order to differentiate the consumption as recreational drugs. There will be also a focus on the analytical methodologies for their analysis, in order to aid health professionals and toxicologists in cases where these compounds are present.
Reference Key
goncalves2019cannabismedicines Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Gonçalves, Joana;Rosado, Tiago;Soares, Sofia;Simão, Ana Y;Caramelo, Débora;Luís, Ângelo;Fernández, Nicolás;Barroso, Mário;Gallardo, Eugenia;Duarte, Ana Paula;
Journal medicines (basel, switzerland)
Year 2019
DOI E31
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.